Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Sarcopenia Treatment Market Growth in 2025?
The market size for sarcopenia treatment has seen promising growth in the past few years. The market, which is projected to rise from $3.52 billion in 2024 to $3.73 billion in 2025, will experience a compound annual growth rate (CAGR) of 6.1%. This historic period growth can be credited to factors such as the aging population, greater awareness and diagnosis, changes in lifestyle, initiatives in public health, and regulatory approvals.
What Is the Forecast for the Sarcopenia Treatment Market Size Through 2029?
The market size for sarcopenia treatment is projected to witness significant expansion in the forthcoming years, surging to a valuation of $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The upswing in the projected timeline can be credited to aspects such as personalized medicine, digital health platforms, nutritional interventions, patient empowerment and education, as well as global health initiatives. The forecast period is set to experience key trends including personalized treatment methods, the introduction of new drug categories, integration of digital health, joint research initiatives, and extensive research and development.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp
What are the Key Market Players in Sarcopenia Treatment Market and How They’re Evolving?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill
What Are the Primary Growth Drivers in the Sarcopenia Treatment Market?
The surge in malnutrition is anticipated to fuel the expansion of the sarcopenia treatment market in the future. Malnutrition is defined as a deficiency, excess, or imbalance in an individual’s consumption of energy and nutrients. It encompasses both undernutrition and overweight-related and diet-related noncommunicable diseases. Sarcopenia treatment aims to tackle the simultaneous occurrence of malnutrition and sarcopenia in the elderly by implementing interventions like nutritional therapy and exercise. The goal is to enhance muscle mass, strength, and overall nutritional health. For example, a report released by the World Health Organization (WHO), a Switzerland-based United Nations (UN) entity, in December 2023, stated that malnutrition continues to be a substantial global health issue. They estimated that 462 million people are underweight and 149 million children under the age of five experienced stunting in 2022. Consequently, the growth of the sarcopenia treatment market is being propelled by the increase in malnutrition.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp
What Are the Leading Segments in the Global Sarcopenia Treatment Industry?
The sarcopenia treatment market covered in this report is segmented –
1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions
What Are the Key Market Trends in the Sarcopenia Treatment Industry?
Major businesses in the sarcopenia treatment market are concentrating their efforts on developing numerous advanced clinical option studies to align with improved treatment methods. A clinical study is a methodical inquiry involving human subjects to determine the safety, effectiveness, and potential outcomes of a medical procedure. As an example, Biophytis, a biotechnology company based in France, received authorization from the US Food and Drug Administration (FDA) in September 2023 to begin the SARA-31 Phase 3 study for sarcopenia. The study’s goal is to assess the safety and efficacy of Sarconeos (BIO101) in treating sarcopenic patients at risk of motor disabilities. This signifies a significant technological and pharmaceutical leap in treating sarcopenia, providing potential benefits in terms of safety and efficacy for serious sarcopenic patients. This is the first phase 3 study in sarcopenia to receive FDA approval. The study will involve approximately 900 sarcopenic patients above the age of 65 with slow walking speed and weak hand grip strength. The primary goal will be to measure the major mobility disability (MMD) risk, walking speed, hand grip strength, and patient self-reported quality of life.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report
What Is the Regional Outlook for the Sarcopenia Treatment Market?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926
This Report Delivers Insight On:
1. How big is the sarcopenia treatment market, and how is it changing globally?
2. Who are the major companies in the sarcopenia treatment market, and how are they performing?
3. What are the key opportunities and risks in the sarcopenia treatment market right now?
4. Which products or customer segments are growing the most in the sarcopenia treatment market?
5. What factors are helping or slowing down the growth of the sarcopenia treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model